Metastatic breast cancer affects people in many ways. The symptoms experienced by each person will vary based on the parts of ...

The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...

Several studies show that isolation is very common among those diagnosed with metastatic breast cancer. However, there are ...

Medically reviewed by Forest Miller, OTR/L When you are managing metastatic breast cancer, planning for the future is both ...

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ ...

The FDA has approved an expanded label for Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test, which ...

DelveInsight’s, “Metastatic Breast Cancer Pipeline Insight” report provides comprehensive insights about 100+ companies and ...

The author reflects on living with HER2-positive metastatic breast cancer for over a decade, highlighting significant milestones and challenges. The eleventh year is viewed as a new beginning, ...

The PATHWAY HER2 (4B5) test, the first and only FDA approved companion diagnostic for assessing HER2-low status since 2022, ...

BriaCell Therapeutics Corp. (BCTX, BCTXW) is down by 4.71 percent during Monday morning trading, following the announcement of a ...

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...